Related Experiment Videos
Pathogenesis of ovarian cancers
A Berchuck1, A Elbendary, L Havrilesky
1Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA.
Journal of the Society for Gynecologic Investigation
|July 1, 1994
Summary
Molecular genetic events in epithelial ovarian cancer are being uncovered. Understanding oncogenes and tumor suppressor genes is key for early diagnosis and improved treatment of this deadly disease.
Area of Science:
- Oncology
- Molecular Genetics
- Cancer Biology
Background:
- Epithelial ovarian cancer (EOC) pathogenesis involves complex molecular genetic alterations.
- Identifying these genetic events is crucial for advancing diagnostic and therapeutic strategies.
Purpose of the Study:
- To review the current understanding of molecular genetic events in epithelial ovarian cancer development.
- To highlight the roles of oncogenes and tumor suppressor genes in EOC.
Main Methods:
- Utilized molecular biologic techniques to investigate gene expression and mutations.
- Examined the involvement of growth-stimulatory genes (oncogenes) and inhibitory genes (tumor suppressors).
Main Results:
- Amplification and overexpression of HER-2/neu and c-myc oncogenes occur in 20-30% of EOC.
- p53 tumor suppressor gene mutations are found in approximately half of advanced EOC cases.
- K-ras oncogene mutations are common in borderline tumors but less so in invasive EOC.
Conclusions:
- Understanding the molecular pathogenesis of EOC is evolving.
- Further research into genetic alterations is essential for improving early diagnosis, treatment, and prevention of EOC.